SEC Filing Summary: Corniche Group Incorporated (10-Q)
Business Context and Reporting Period
This is a Quarterly Report on Form 10-Q for Corniche Group Incorporated (not Lisata Therapeutics, Inc., as indicated in the metadata request) for the period ended March 31, 2001. The Company operates in the property and casualty specialty insurance and service contract markets. Its primary revenue source is the sale of extended warranty service contracts via the Internet and strategic partnerships. The Company recently completed a strategic shift to focus on co-branding and private labeling with partners.
Key Financial Metrics
| Metric | Q1 2001 | Q1 2000 |
|---|---|---|
| Revenue (Earned) | $11,457 | $1,479 |
| Gross Profit | $4,042 | $(7,463) |
| Operating Loss | $(418,134) | $(307,132) |
| Net Loss (Continuing Ops) | $(402,272) | $(284,371) |
| Net Loss (Total) | $(652,777) | $(199,141) |
| Cash and Equivalents | $45,569 | $85,604 |
| Marketable Securities | $2,048,069 | $2,376,214 |
| Total Debt (Current + Long-term) | $71,565 | $76,591 |
| Accrued Preferred Dividends | $302,064 | $290,143 |
Material Changes vs. Prior Period
- Discontinued Operations: The Company recorded a significant loss on disposal of $431,857 related to its subsidiary, Stamford Insurance Company, Ltd. The Board approved the sale of Stamford for $372,000, with closing expected by June 30, 2001. This charge drove the total Net Loss to $(652,777), compared to $(199,141) in the prior year.
- Operating Expenses: General and administrative expenses increased by approximately 40.6% to $422,176. This was driven by increased web development costs ($58,000), staff costs ($49,000), and professional fees ($38,000), partially offset by a reduction in advertising spend ($52,000).
- Liquidity: Cash and equivalents decreased by $40,035 to $45,569. The Company utilized $328,145 from marketable securities to fund operating activities, which resulted in a net cash outflow from operations of $363,154.
- Revenue Recognition: While gross revenues from sales were $72,000, only $11,457 was recognized as earned revenue due to the ratable recognition policy over contract life.
Guidance, Outlook, and Risks
- Outlook: Management anticipates achieving break-even operating cash flow by the end of fiscal year 2001. The strategy relies on reducing advertising spend (targeting <$200,000 for fiscal 2001) and generating 90% of revenue through strategic partnerships.
- Liquidity Plan: The Company plans to fund operations in the first half of 2001 using cash reserves and Treasury notes. Proceeds from the sale of Stamford ($372,000) are expected in the near future.
- Risks: There is no assurance that the Company will successfully enter strategic partnerships or secure alternate funding if required. The Company has a significant accumulated deficit of $(7,049,347) and relies on the conversion or redemption of preferred stock terms.
- Unusual Items: The $432,000 charge for the disposal of Stamford is a non-recurring item. Additionally, the Company issued 2,625 shares of common stock valued at $735 for director fees during the quarter.
Investor Verification Checklist
- Verify the closing date and final proceeds of the Stamford Insurance Company sale to Butler Financial Solutions, LLC.
- Confirm the status of the $302,064 in accrued Series A preferred dividends and any potential redemption or conversion activity.
- Monitor the execution of the strategic partnership model to ensure the projected 90% revenue shift from direct sales to partnerships materializes.
- Review the burn rate of cash reserves ($45,569) against the projected $150,000 investment needed for the remainder of fiscal 2001 to maintain the website.
- Check for any updates on the utilization of Net Operating Loss (NOL) carryforwards, which are currently fully reserved due to ownership change limitations.